Skip to main content
Log in

Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman–Sacks endocarditis

  • Case Report
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Hypertrophic obstructive cardiomyopathy in Libman–Sacks endocarditis is quite rare and the correct etiological relationship between them is unknown. Some changes may cause a secondary disorganization of the ordinary muscle structure, making a disarray pattern with irregular interwoven myocyte fibers. This case report describes one of the first cases of ventricular septal myectomy and mitral valve replacement for hypertrophic obstructive cardiomyopathy and mitral valve regurgitation associated with Libman–Sacks endocarditis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–37.

    Article  Google Scholar 

  2. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–16.

    Article  Google Scholar 

  3. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6.

    Article  Google Scholar 

  4. Arbustini E, Narula N, Tavazzi L, et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol. 2014;64:304–18.

    Article  Google Scholar 

  5. Anastasiadis GP, Moyssakis I, Boki K, Kyriakidis M. Hypertrophic cardiomyopathy in systemic lupus erythematosus. Mayo Clin Proc. 2001;71:111.

    Article  Google Scholar 

  6. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257–65.

    Article  CAS  Google Scholar 

  7. Asherson RA, Ames D, Coltart J, Byrne C, Hughes GR. Hypertrophic cardiomyopathy in systemic lupus erythematosus and “lupus-like” disease. Chance association? A report of 2 cases. J Rheumatol. 1992;19:1973–7.

    CAS  PubMed  Google Scholar 

  8. Kotani T, Takeuchi T, Sakamoto M, et al. A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28(6):413–7.

    Article  Google Scholar 

  9. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424.

    Article  CAS  Google Scholar 

  10. Kotkar KD, Said SM. Libman–Sacks endocarditis in a patient with antiphospholipid syndrome. Ann Thorac Surg. 2016;102:e31–2.

    Article  Google Scholar 

Download references

Acknowledgements

The authors have nothing to disclose with regard to commercial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Go Yamashita.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamashita, G., Kanemitsu, N., Nakashima, Y. et al. Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman–Sacks endocarditis. Gen Thorac Cardiovasc Surg 68, 181–184 (2020). https://doi.org/10.1007/s11748-018-1042-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-018-1042-7

Keywords

Navigation